Sentinel BioTherapeutics
PrivateLast Round
Seed
May 29, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sentinel BioTherapeutics operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Seed round in May 2025.
Sentinel BioTherapeutics is a biotechnology company that develops localized cytokine immunotherapies using encapsulated allogeneic cell-based protein producers to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sentinel BioTherapeutics Comparables
Compare Sentinel BioTherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aulos Bioscience | 75% | |
| Imunon Inc | 74% | |
| Xilio Therapeutics | 72% |
For institutional investors. Book with your work email.
Sentinel BioTherapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 61% MoM, reaching 1K.
- Jul 27, 2026
Monthly visitors increased 1320% MoM, from 45 to 639.
For institutional investors. Book with your work email.
Sentinel BioTherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sentinel BioTherapeutics's valuation, stock price, and market status.
Is Sentinel BioTherapeutics a public or private company?
Sentinel BioTherapeutics is a private company.
What is the current stock price of Sentinel BioTherapeutics?
Sentinel BioTherapeutics is a private company, so its shares have no public market price. Caplight tracks Sentinel BioTherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sentinel BioTherapeutics worth (valuation)?
Valuation information for Sentinel BioTherapeutics is not publicly available.
Can I buy Sentinel BioTherapeutics stock?
Sentinel BioTherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sentinel BioTherapeutics's last funding round?
Sentinel BioTherapeutics's most recent funding round was Seed on May 29, 2025.
Who are the main investors in Sentinel BioTherapeutics?
Investor information for Sentinel BioTherapeutics is not publicly disclosed.
Will Sentinel BioTherapeutics IPO soon?
No public IPO plans have been announced for Sentinel BioTherapeutics.
How can I track Sentinel BioTherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Sentinel BioTherapeutics's shares on secondary markets.